Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Eurostarsprojekt, E! 9215 IMAID Redoxis AB

Reference number
Coordinator Redoxis AB - Redoxis AB, Lund
Funding from Vinnova SEK 3 321 556
Project duration April 2015 - March 2018
Status Completed
Venture Eurostars

Purpose and goal

The aim of this program was to develop a service for evaluation of effects of inflammatory disease in preclinical models of autoimmune disease. We have during the program, efficiently evaluated and standardized procedures and developed a service that is now being marketed to customers, well in line with the goal of the program.

Expected effects and result

We have developed a marketable service that are now being presented to potential customers.

Planned approach and implementation

The program has been advancing well with one delay due to exchange of MRI equipment. All planned experiments and analyses have been performed and reports have been prepared.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 30 September 2019

Reference number 2015-00561

Page statistics